Global Bipolar Disorder Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Bipolar Disorder Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 Bipolar I Disorder
1.3.3 Bipolar II Disorder
1.3.4 Cyclothymic Disorder
1.4 Market by Application
1.4.1 Global Bipolar Disorder Market Share by Application: 2020 VS 2026
1.4.2 Mood Stabilizers
1.4.3 Anticonvulsants
1.4.4 Antipsychotic drugs
1.4.5 Antidepressant drugs
1.4.6 Antianxiety drugs
1.4.7 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Market Perspective (2015-2026)
2.2 Bipolar Disorder Growth Trends by Regions
2.2.1 Bipolar Disorder Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bipolar Disorder Historic Market Share by Regions (2015-2020)
2.2.3 Bipolar Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Bipolar Disorder Industry Dynamic
2.3.1 Bipolar Disorder Market Trends
2.3.2 Bipolar Disorder Market Drivers
2.3.3 Bipolar Disorder Market Challenges
2.3.4 Bipolar Disorder Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Players by Market Size
3.1.1 Global Top Bipolar Disorder Players by Revenue (2015-2020)
3.1.2 Global Bipolar Disorder Revenue Market Share by Players (2015-2020)
3.2 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Revenue
3.4 Global Bipolar Disorder Market Concentration Ratio
3.4.1 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Revenue in 2019
3.5 Key Players Bipolar Disorder Area Served
3.6 Key Players Bipolar Disorder Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Breakdown Data by Type
4.1 Global Bipolar Disorder Historic Market Size by Type (2015-2020)
4.2 Global Bipolar Disorder Forecasted Market Size by Type (2021-2026)
5 Bipolar Disorder Breakdown Data by Application
5.1 Global Bipolar Disorder Historic Market Size by Application (2015-2020)
5.2 Global Bipolar Disorder Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bipolar Disorder Market Size (2015-2026)
6.2 North America Bipolar Disorder Market Size by Type (2015-2020)
6.3 North America Bipolar Disorder Market Size by Application (2015-2020)
6.4 North America Bipolar Disorder Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Bipolar Disorder Market Size (2015-2026)
7.2 Europe Bipolar Disorder Market Size by Type (2015-2020)
7.3 Europe Bipolar Disorder Market Size by Application (2015-2020)
7.4 Europe Bipolar Disorder Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bipolar Disorder Market Size (2015-2026)
8.2 Asia-Pacific Bipolar Disorder Market Size by Type (2015-2020)
8.3 Asia-Pacific Bipolar Disorder Market Size by Application (2015-2020)
8.4 Asia-Pacific Bipolar Disorder Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Bipolar Disorder Market Size (2015-2026)
9.2 Latin America Bipolar Disorder Market Size by Type (2015-2020)
9.3 Latin America Bipolar Disorder Market Size by Application (2015-2020)
9.4 Latin America Bipolar Disorder Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bipolar Disorder Market Size (2015-2026)
10.2 Middle East & Africa Bipolar Disorder Market Size by Type (2015-2020)
10.3 Middle East & Africa Bipolar Disorder Market Size by Application (2015-2020)
10.4 Middle East & Africa Bipolar Disorder Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Glaxo SmithKline (GSK)
11.1.1 Glaxo SmithKline (GSK) Company Details
11.1.2 Glaxo SmithKline (GSK) Business Overview
11.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
11.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2015-2020))
11.1.5 Glaxo SmithKline (GSK) Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Bipolar Disorder Introduction
11.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2015-2020)
11.2.5 Pfizer Inc. Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Details
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2015-2020)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorder Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2015-2020)
11.4.5 Eli Lilly Recent Development
11.5 Allergan Plc.
11.5.1 Allergan Plc. Company Details
11.5.2 Allergan Plc. Business Overview
11.5.3 Allergan Plc. Bipolar Disorder Introduction
11.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2015-2020)
11.5.5 Allergan Plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Bipolar Disorder Introduction
11.6.4 Novartis AG Revenue in Bipolar Disorder Business (2015-2020)
11.6.5 Novartis AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Bipolar Disorder Introduction
11.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2015-2020)
11.7.5 AbbVie Inc. Recent Development
11.8 Otsuka Holdings Ltd
11.8.1 Otsuka Holdings Ltd Company Details
11.8.2 Otsuka Holdings Ltd Business Overview
11.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
11.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2015-2020)
11.8.5 Otsuka Holdings Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorder Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2015-2020)
11.9.5 AstraZeneca Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Bipolar Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of Bipolar I Disorder
Table 3. Key Players of Bipolar II Disorder
Table 4. Key Players of Cyclothymic Disorder
Table 5. Global Bipolar Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Bipolar Disorder Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Bipolar Disorder Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Bipolar Disorder Market Share by Regions (2015-2020)
Table 9. Global Bipolar Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Bipolar Disorder Market Share by Regions (2021-2026)
Table 11. Bipolar Disorder Market Market Trends
Table 12. Bipolar Disorder Market Drivers
Table 13. Bipolar Disorder Market Challenges
Table 14. Bipolar Disorder Market Restraints
Table 15. Global Bipolar Disorder Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Bipolar Disorder Market Share by Players (2015-2020)
Table 17. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder as of 2019)
Table 18. Global Bipolar Disorder by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bipolar Disorder Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Bipolar Disorder Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Bipolar Disorder Revenue Market Share by Type (2015-2020)
Table 24. Global Bipolar Disorder Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 25. Global Bipolar Disorder Market Size Share by Application (2015-2020) (US$ Million)
Table 26. Global Bipolar Disorder Revenue Market Share by Application (2015-2020)
Table 27. Global Bipolar Disorder Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 28. North America Bipolar Disorder Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Bipolar Disorder Market Share by Type (2015-2020)
Table 30. North America Bipolar Disorder Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Bipolar Disorder Market Share by Application (2015-2020)
Table 32. North America Bipolar Disorder Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Bipolar Disorder Market Share by Country (2015-2020)
Table 34. Europe Bipolar Disorder Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Bipolar Disorder Market Share by Type (2015-2020)
Table 36. Europe Bipolar Disorder Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Bipolar Disorder Market Share by Application (2015-2020)
Table 38. Europe Bipolar Disorder Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Bipolar Disorder Market Share by Country (2015-2020)
Table 40. Asia-Pacific Bipolar Disorder Market Size by Type (2015-2020) (US$ Million)
Table 41. Asia-Pacific Bipolar Disorder Market Share by Type (2015-2020)
Table 42. Asia-Pacific Bipolar Disorder Market Size by Application (2015-2020) (US$ Million)
Table 43. Asia-Pacific Bipolar Disorder Market Share by Application (2015-2020)
Table 44. Asia-Pacific Bipolar Disorder Market Size by Region (US$ Million) (2015-2020)
Table 45. Asia-Pacific Bipolar Disorder Market Share by Region (2015-2020)
Table 46. Latin America Bipolar Disorder Market Size by Type (2015-2020) (US$ Million)
Table 47. Latin America Bipolar Disorder Market Share by Type (2015-2020)
Table 48. Latin America Bipolar Disorder Market Size by Application (2015-2020) (US$ Million)
Table 49. Latin America Bipolar Disorder Market Share by Application (2015-2020)
Table 50. Latin America Bipolar Disorder Market Size by Country (US$ Million) (2015-2020)
Table 51. Latin America Bipolar Disorder Market Share by Country (2015-2020)
Table 52. Middle East & Africa Bipolar Disorder Market Size by Type (2015-2020) (US$ Million)
Table 53. Middle East & Africa Bipolar Disorder Market Share by Type (2015-2020)
Table 54. Middle East & Africa Bipolar Disorder Market Size by Application (2015-2020) (US$ Million)
Table 55. Middle East & Africa Bipolar Disorder Market Share by Application (2015-2020)
Table 56. Middle East & Africa Bipolar Disorder Market Size by Country (US$ Million) (2015-2020)
Table 57. Middle East & Africa Bipolar Disorder Market Share by Country (2015-2020)
Table 58. Glaxo SmithKline (GSK) Company Details
Table 59. Glaxo SmithKline (GSK) Business Overview
Table 60. Glaxo SmithKline (GSK) Bipolar Disorder Product
Table 61. Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 62. Glaxo SmithKline (GSK) Recent Development
Table 63. Pfizer Inc. Company Details
Table 64. Pfizer Inc. Business Overview
Table 65. Pfizer Inc. Bipolar Disorder Product
Table 66. Pfizer Inc. Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 67. Pfizer Inc. Recent Development
Table 68. Janssen Pharmaceuticals Company Details
Table 69. Janssen Pharmaceuticals Business Overview
Table 70. Janssen Pharmaceuticals Bipolar Disorder Product
Table 71. Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 72. Janssen Pharmaceuticals Recent Development
Table 73. Eli Lilly Company Details
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Bipolar Disorder Product
Table 76. Eli Lilly Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Allergan Plc. Company Details
Table 79. Allergan Plc. Business Overview
Table 80. Allergan Plc. Bipolar Disorder Product
Table 81. Allergan Plc. Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 82. Allergan Plc. Recent Development
Table 83. Novartis AG Company Details
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Bipolar Disorder Product
Table 86. Novartis AG Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 87. Novartis AG Recent Development
Table 88. AbbVie Inc. Company Details
Table 89. AbbVie Inc. Business Overview
Table 90. AbbVie Inc. Bipolar Disorder Product
Table 91. AbbVie Inc. Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 92. AbbVie Inc. Recent Development
Table 93. Otsuka Holdings Ltd Business Overview
Table 94. Otsuka Holdings Ltd Bipolar Disorder Product
Table 95. Otsuka Holdings Ltd Company Details
Table 96. Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 97. Otsuka Holdings Ltd Recent Development
Table 98. AstraZeneca Company Details
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Bipolar Disorder Product
Table 101. AstraZeneca Revenue in Bipolar Disorder Business (2015-2020) (US$ Million)
Table 102. AstraZeneca Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Bipolar Disorder Market Share by Type: 2020 VS 2026
Figure 2. Bipolar I Disorder Features
Figure 3. Bipolar II Disorder Features
Figure 4. Cyclothymic Disorder Features
Figure 5. Global Bipolar Disorder Market Share by Application: 2020 VS 2026
Figure 6. Mood Stabilizers Case Studies
Figure 7. Anticonvulsants Case Studies
Figure 8. Antipsychotic drugs Case Studies
Figure 9. Antidepressant drugs Case Studies
Figure 10. Antianxiety drugs Case Studies
Figure 11. Others Case Studies
Figure 12. Bipolar Disorder Report Years Considered
Figure 13. Global Bipolar Disorder Market Size (US$ Million), YoY Growth 2015-2026
Figure 14. Global Bipolar Disorder Market Share by Regions: 2020 VS 2026
Figure 15. Global Bipolar Disorder Market Share by Regions (2021-2026)
Figure 16. Global Bipolar Disorder Market Share by Players in 2019
Figure 17. Global Top Bipolar Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Bipolar Disorder Revenue in 2019
Figure 19. North America Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. United States Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Canada Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Europe Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Germany Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. France Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. U.K. Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Italy Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Russia Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Nordic Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Bipolar Disorder Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Glaxo SmithKline (GSK) Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 45. Pfizer Inc. Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 46. Janssen Pharmaceuticals Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 47. Eli Lilly Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 48. Allergan Plc. Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 49. Novartis AG Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 50. AbbVie Inc. Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 51. Otsuka Holdings Ltd Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 52. AstraZeneca Revenue Growth Rate in Bipolar Disorder Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed